Table 3.
Changes in plasma concentrations of biomarkers, by study group.
| Control group | Intervention group | Between-groups p-value | |||||
|---|---|---|---|---|---|---|---|
| Baseline | Final | Intragroup p-value | Baseline | Final | Intragroup p-value | ||
| BDNF (pg/ml) | 260.0 | 149.6 | 0.35 | 20.63 | 207.1 | 0.028 | 0.005 |
| Cathepsin D (pg/ml) | 4,824 | 3,559 | 0.92 | 3,637 | 3,716 | 0.50 | 0.63 |
| sICAM-1 (pg/ml) | 1,899 | 1,546 | 0.23 | 2,145 | 1,546 | 0.043 | 0.41 |
| MPO (pg/ml) | 28,150 | 3,559 | 0.14 | 46,992 | 3,733 | 0.080 | 0.78 |
| PDGF-AA (pg/ml) | 143.3 | 83.4 | 0.50 | 23.8 | 157.6 | 0.028 | 0.13 |
| RANTES (pg/ml) | 837.3 | 1,210 | 0.18 | 202 | 2,850 | 0.18 | 0.03 |
| NCAM (pg/ml) | 6,387 | 5,731 | 0.87 | 8,152 | 8,198 | 0.75 | 0.43 |
| PDGF-AB/BB (pg/ml) | 576.9 | 399.2 | 0.74 | 16.4 | 336.4 | 0.028 | 0.96 |
| sVCAM-1 (pg/ml) | 2,916 | 2,645 | 0.25 | 2,968 | 3,202 | 0.46 | 0.36 |